Differential effects of two probiotics on the risks of eczema and atopy associated with single nucleotide polymorphisms to Toll-like receptors

Pediatric Allergy and Immunology

Volumn 26, Issue 3, 2015, Pages 262-271

  Marlow, Gareth ^a   Han, Dug Yeo ^a   Wickens, Kristin ^b   Stanley, Thorsten ^b   Crane, Julian ^b   Mitchell, Edwin A ^a   Dekker, James ^c   Barthow, Christine ^b   Fitzharris, Penny ^d   Ferguson, Lynnette R ^a   Morgan, Angharad R ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c FONTERRA RESEARCH CENTRE   (New Zealand)

^d AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

Atopy; Bifidobacterium animalis subsp. lactis HN019; Eczema; Infants; Lactobacillus rhamnosus HN001; Probiotics; SNPs; Toll like receptors

Indexed keywords

PROBIOTIC AGENT; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9;

ARTICLE; ASTHMA; ATOPY; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS HN019; CONTACT SENSITIZATION; CONTROLLED STUDY; ECZEMA; FAMILY HISTORY; GENETIC PREDISPOSITION; GENOTYPE; HIGH RISK INFANT; HUMAN; IMMUNOLOGICAL TOLERANCE; INFANT; LACTOBACILLUS RHAMNOSUS; LACTOBACILLUS RHAMNOSUS HN001; NONHUMAN; POLLEN ALLERGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN SENSITIZATION; BIFIDOBACTERIUM; CAUCASIAN; DERMATITIS, ATOPIC; DIET SUPPLEMENTATION; DIET THERAPY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; GENETICS; IMMUNOLOGY; NEWBORN; PLACEBO EFFECT; PREGNANCY; PRESCHOOL CHILD; RISK;

BIFIDOBACTERIUM; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; ECZEMA; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; INFANT, NEWBORN; LACTOBACILLUS RHAMNOSUS; PLACEBO EFFECT; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; PROBIOTICS; RISK; TOLL-LIKE RECEPTORS;

EID: 84928173892     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/pai.12371     Document Type: Article

References (41)

1. Leung DY, Bieber T. Atopic dermatitis. Lancet 2003: 361: 151-60.
2. Wadonda-Kabondo N, Sterne JA, Golding J, et al. Association of parental eczema, hayfever, and asthma with atopic dermatitis in infancy: birth cohort study. Arch Dis Child 2004: 89: 917-21.
3. Larsen FS. Atopic dermatitis: a genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol 1993: 28: 719-23.
4. Esparza-Gordillo J, Weidinger S, Folster-Holst R, et al. A common variant on chromosome 11q13 is associated with atopic dermatitis. Nat Genet 2009: 41: 596-601.
5. Ahmad-Nejad P, Mrabet-Dahbi S, Breuer K, et al. The Toll-like receptor 2 R753Q polymorphism defines a subgroup of patients with atopic dermatitis having severe phenotype. J Allergy Clin Immunol 2004: 113: 565-7.
6. Oh DY, Schumann RR, Hamann L, et al. Association of the toll-like receptor 2 A-16934T promoter polymorphism with severe atopic dermatitis. Allergy 2009: 64: 1608-15.
7. Ismail IH, Oppedisano F, Joseph SJ, et al. Reduced gut microbial diversity in early life is associated with later development of eczema but not atopy in high-risk infants. Pediatr Allergy Immunol 2012: 23: 674-81.
8. Abrahamsson TR, Jakobsson HE, Andersson AF, et al. Low diversity of the gut microbiota in infants with atopic eczema. J Allergy Clin Immunol 2012: 129: 434-40, 440 e431-432.
9. Wang M, Karlsson C, Olsson C, et al. Reduced diversity in the early fecal microbiota of infants with atopic eczema. J Allergy Clin Immunol 2008: 121: 129-34.
10. Hemarajata P, Versalovic J. Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation. Therap Adv Gastroenterol 2013: 6: 39-51.
11. Kalliomaki M, Salminen S, Poussa T, et al. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol 2007: 119: 1019-21.
12. Kukkonen K, Savilahti E, Haahtela T, et al. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 2007: 119: 192-8.
13. Prescott SL, Björkstén B. Probiotics for the prevention or treatment of allergic diseases. J Allergy Clin Immunol 2007: 120: 255-62.
14. Gill HS, Rutherfurd KJ, Prasad J, et al. Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019). Br J Nutr 2000: 83: 167-76.
15. Tesse R, Pandey RC, Kabesch M. Genetic variations in toll-like receptor pathway genes influence asthma and atopy. Allergy 2011: 66: 307-16.
16. Novak N, Yu CF, Bussmann C, et al. Putative association of a TLR9 promoter polymorphism with atopic eczema. Allergy 2007: 62: 766-72.
17. Cook DN, Pisetsky DS, Schwartz DA. Toll-like receptors in the pathogenesis of human disease. Nat Immunol 2004: 5: 975-9.
18. Schroder NW, Schumann RR. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect Dis 2005: 5: 156-64.
19. Forsberg A, Abrahamsson TR, Bjorksten B, et al. Pre- and postnatal administration of Lactobacillus reuteri decreases TLR2 responses in infants. Clin Transl Allergy 2014: 4: 21.
20. Taylor A, Hale J, Wiltschut J, et al. Evaluation of the effects of probiotic supplementation from the neonatal period on innate immune development in infancy. Clin Exp Allergy 2006: 36: 1218-26.
21. Wickens K, Black PN, Stanley TV, et al. A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 2008: 122: 788-94.
22. Williams HC, Burney PG, Pembroke AC, et al. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation. Br J Dermatol 1994: 131: 406-16.
23. Wickens K, Black P, Stanley TV, et al. A protective effect of Lactobacillus rhamnosus HN001 against eczema in the first 2 years of life persists to age 4 years. Clin Exp Allergy 2012: 42: 1071-9.
24. Severity scoring of atopic dermatitis: the SCORAD index. Consensus report of the European task force on atopic dermatitis. Dermatology 1993: 186: 23-31.
25. ASCIA skin prick testing working party: Skin prick testing for the diagnosis of allergic disease. A manual for practitioners. In.; 2009.
26. Kormann MSD, Depner M, Hartl D, et al. Toll-like receptor heterodimer variants protect from childhood asthma. J Allergy Clin Immunol 2008: 122: 86-92.e88.
27. Kormann MSD, Ferstl R, Depner M, et al. Rare TLR2 mutations reduce TLR2 receptor function and can increase atopy risk. Allergy 2009: 64: 636-42.
28. Pellerin L, Jenks JA, Begin P, et al. Regulatory T cells and their roles in immune dysregulation and allergy. Immunol Res 2014: 58: 358-68.
29. Lesiak A, Smolewski P, Sobolewska-Sztychny D, et al. The role of T-regulatory cells and Toll-like receptors 2 and 4 in atopic dermatitis. Scand J Immunol 2012: 76: 405-10.
30. Kalliomaki M, Isolauri E. Role of intestinal flora in the development of allergy. Curr Opin Allergy Clin Immunol 2003: 3: 15-20.
31. West CE, Jenmalm MC, Prescott SL. The gut microbiota and its role in the development of allergic disease: a wider perspective. Clin Exp Allergy 2015: 45: 43-53.
32. Bermudez-Brito M, Plaza-Diaz J, Munoz-Quezada S, et al. Probiotic mechanisms of action. Ann Nutr Metab 2012: 61: 160-74.
33. de Kivit S, Tobin MC, Forsyth CB, et al. Regulation of intestinal immune responses through TLR activation: implications for Pro- and prebiotics. Front Immunol 2014: 5: 60.
34. Good M, Sodhi CP, Ozolek JA, et al. Lactobacillus rhamnosus HN001 decreases the severity of necrotizing enterocolitis in neonatal mice and preterm piglets: evidence in mice for a role of TLR9. Am J Physiol Gastrointest Liver Physiol 2014: 306: G1021-32.
35. Wickens K, Stanley TV, Mitchell EA, et al. Early supplementation with Lactobacillus rhamnosus HN001 reduces eczema prevalence to 6 years: does it also reduce atopic sensitization? Clin Exp Allergy 2013: 43: 1048-57.
36. Ganguli K, Collado MC, Rautava J, et al. Lactobacillus rhamnosus GG and its SpaC pilus adhesin modulate inflammatory responsiveness and TLR-related gene expression in the fetal human gut. Pediatr Res 2015: 77: 528-35.
37. Morgan AR, Han DY, Wickens K, et al. Differential modification of genetic susceptibility to childhood eczema by two probiotics. Clin Exp Allergy 2014: 44: 1255-65.
38. Osborn DA, Sinn JK. Probiotics in infants for prevention of allergic disease and food hypersensitivity. Cochrane Database Syst Rev 2007 Oct 17;(4): CD006475.
39. Tulic MK, Wale JL, Holt PG, et al. Modification of the inflammatory response to allergen challenge after exposure to bacterial lipopolysaccharide. Am J Respir Cell Mol Biol 2000: 22: 604-12.
40. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004: 4: 499-511.
41. Lee CC, Avalos AM, Ploegh HL. Accessory molecules for Toll-like receptors and their function. Nat Rev Immunol 2012: 12: 168-79.